NanoViricides is a nano-biopharmaceutical research and development company focusing on the discovery, development, and commercialization of drugs for viral infections using its nanomedicines technology. Co.'s drug programs are: CoronaVirus Program; HerpeCide Program, which includes NV-HHV-1 Dermal Topical, NV-HHV-1 Oral Gummies, Oral Syrup, and Injectable Solution, for Injection or Infusion; Monkeypox Treatment; Adenovirus 71 Treatment; HerpeCide Program Expansion Drug Projects; HIVCide ; FluCide Broad-Spectrum Anti-Influenza nanoviricide; Nanoviricide Eye Drops; DengueCide; Other Nanoviricides Drug Projects; and Long Term Projects.
|
Free NNVC Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Strong Buy (4.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |